Dr. Young on Eltrombopag Added to Immunosuppression for Patients With Aplastic Anemia
December 5th 2015
Neal Young, MD, senior investigator, Cell Biology Section, National Heart, Lung, and Blood Institute, National Institute of Health, discusses a study that examined the efficacy of eltrombopag when added to standard immunosuppression for patients with aplastic anemia.